A drug called niraparib showed clinically relevant activity in women with relapsed ovarian cancer who had exhausted all previous treatment options, according to a recent study.
Northwestern investigators are building a multi-disciplinary enterprise that is making critical discoveries in maternal-fetal health, with significant clinical implications and real-world consequences.
Northwestern scientists came together to discuss the importance of women’s health research and mark the third anniversary of a landmark sex-inclusion policy by the NIH.
Northwestern scientists have successfully transformed induced pluripotent stem cells into endometrial cells, which line the uterus and are involved in several uterine conditions such as endometrial cancer and infertility.
Minimally invasive hysterectomy results in worse overall survival outcomes for cancer patients than traditional open surgery, according to a new study.
The inaugural Women in Medicine Symposium brought together faculty, scientists, trainees and students to highlight achievements of women faculty and identify ongoing challenges in career development.
Maya Jackson-Gibson, a second-year medical student, is a leader in the groups Medical Students for Choice and the Student National Medical Association.
A drug called bevacizumab added to adjuvant chemotherapy did not improve outcomes for patients with a form of high-risk breast cancer, according to a study published in the Journal of Clinical Oncology.
A drug called palbociclib, used in combination with standard treatment, improved survival for women with hormone receptor-positive metastatic breast cancer.
Teresa Woodruff, PhD, vice chair for research in the Department of Obstetrics and Gynecology and dean of the Graduate School, has been elected to the National Academy of Medicine.